Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT capsules in cirrhosis and hepatic encephalopathy
NCT03152188Phase 1Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Jun 2017
- Primary completion
- Nov 2018
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in hepatic encephalopathy (HE) comparing FMT Arm with Placebo Arm (2 arms). Primary endpoint: Serious Adverse events related to FMT at 5 months. Started Jun 2017; status: completed.
02
Drugs
allogeneic fecal microbiota
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT03152188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03152188.